Moreover, the above doses of Oxaliplatin and DHA treatment in various CRC cells significantly reduced cell viability and elevated the number of Annexin V/propidium iodide (PI) double-stained cells compared to single treatments with each agent (Figure 1D,E). Here, ANXA5 is linked to colorectal carcinoma.